ACC 2021

Electrophysiology

Favourable outcomes with transcatheter atrial appendage occlusion

Presented By

Dr Matthew Price, Scripps Clinic, USA

Trial

PROTECT AF, PREVAIL

Conference

ACC 2021

9 July, 2021 23:31

Etripamil nasal spray significantly improves PSVT-related symptoms

Presented By

Dr Bruce Stambler, Piedmont Heart Institute, USA

Trial

Phase 3, NODE-301

Conference

ACC 2021

9 July, 2021 22:38

Ablation-based rhythm control as effective as rate control in AF and HF

Presented By

Prof. Anthony Tang, University of Ottawa, Canada

Trial

RAFT-AF

Conference

ACC 2021

9 July, 2021 14:41

Finerenone reduces the risk of AF onset in patients with CKD and diabetes

Presented By

Prof. Gerasimos Filippatos, Attikon University Hospital, Greece

Trial

Phase 3, FIDELIO-DKD

Conference

ACC 2021

9 July, 2021 13:46

Heart Failure and Cardiomyopathy

PARADISE-MI: Sacubitril/valsartan not superior to ramipril in reducing HF events

Presented By

Prof. Marc Pfeffer, Brigham and Women’s Hospital, USA

Trial

Phase 3, PARADISE-MI

Conference

ACC 2021

9 July, 2021 23:29

Older adults with heart failure benefit from rehabilitation programme

Presented By

Dr Dalane Kitzman , Wake Forest School of Medicine, NC, USA

Trial

REHAB-HF

Conference

ACC 2021

9 July, 2021 21:42

Quality improvement intervention fails to improve care for patients with heart failure

Presented By

Prof. Adam DeVore, Duke University School of Medicine, USA

Trial

CONNECT-HF

Conference

ACC 2021

9 July, 2021 20:54

Sacubitril/valsartan does not reduce NT-proBNP versus valsartan alone in HFrEF

Presented By

Prof. Douglas Mann, Washington School of Medicine, USA

Trial

Phase 4, LIFE

Conference

ACC 2021

9 July, 2021 19:02

Novel use of ivabradine in reversible cardiomyopathy

Presented By

Dr Eric Torkildsen, Lehigh Valley Health Network, USA

Conference

ACC 2021

9 July, 2021 18:15

Mavacamten significantly improves QoL of patients with hypertrophic cardiomyopathy

Presented By

Prof. John Spertus, Saint Luke’s Mid America Heart Institute, USA

Trial

Phase 3, EXPLORER-HCM

Conference

ACC 2021

15 May, 2021 22:34

Interventional and Structural Cardiology

Men and women benefit equally from early aspirin withdrawal following PCI

Presented By

Dr Birgit Vogel, Icahn School of Medicine, USA

Trial

TWILIGHT

Conference

ACC 2021

9 July, 2021 23:24

Similar outcomes with fractional flow reserve and angiography-guided revascularisation

Presented By

Dr Etienne Puymirat, Hôpital Européen Georges-Pompidou

Trial

FLOWER-MI

Conference

ACC 2021

9 July, 2021 22:30

TALOS-AMI: Exploring outcomes after switching to clopidogrel versus ticagrelor at 1 month from MI

Presented By

Prof. Kiyuk Chang, Seoul St. Mary’s Hospital, South Korea

Trial

TALOS-AMI

Conference

ACC 2021

9 July, 2021 20:46

Clopidogrel monotherapy associated with better net outcomes relative to aspirin monotherapy 6-18 months after PCI

Presented By

Prof. Hyo-Soo Kim, Seoul National University Hospital, South Korea

Trial

HOST-EXAM

Conference

ACC 2021

9 July, 2021 19:52

Ischaemic Heart Disease

No difference in ischaemic risk or bleeding with low vs high-dose aspirin for secondary prevention: Lessons and questions from the ADAPTABLE trial

Presented By

Prof. William Schuyler Jones , Duke Clinical Research Institute, USA

Trial

ADAPTABLE

Conference

ACC 2021

9 July, 2021 23:03

Rivaroxaban reduces total ischaemic events after peripheral artery revascularisation

Presented By

Dr Rupert Bauersachs, Klinikum Darmstadt, Germany

Trial

VOYAGER PAD

Conference

ACC 2021

9 July, 2021 22:13

Moderate hypothermia not superior to mild hypothermia following out-of-hospital cardiac arrest

Presented By

Dr Michel Le May , University of Ottawa, Canada

Trial

CAPITAL-CHILL

Conference

ACC 2021

9 July, 2021 21:16

Better outcomes with invasive strategy if anatomic complete revascularisation is possible

Presented By

Dr Gregg Stone, Mount Sinai Medical Centre, USA

Trial

ISCHEMIA

Conference

ACC 2021

9 July, 2021 10:20

Prevention and Health Promotion

STRENGTH trial fails to demonstrate cardioprotective effect of omega-3 fatty acids

Presented By

Dr Steven Nissen, Cleveland Clinic, USA

Trial

STRENGTH, REDUCE-IT

Conference

ACC 2021

9 July, 2021 23:25

Evinacumab lowers triglyceride levels in severe hypertriglyceridaemia

Presented By

Dr Robert Rosenson, Icahn School of Medicine at Mount Sinai, USA

Conference

ACC 2021

9 July, 2021 22:29

Health equity and the role of the cardiologist: 7 priorities to consider

Presented By

Prof. Michelle Albert, University of California, USA

Conference

ACC 2021

9 July, 2021 17:39

COVID-19

Dapagliflozin fails to show a significant protective effect in COVID-19

Presented By

Prof. Mikhail Kosiborod, Saint Luke’s Mid America Heart Institute, USA

Trial

DARE-19

Conference

ACC 2021

9 July, 2021 23:46

Therapeutic anticoagulation not superior to prophylactic anticoagulation in COVID-19

Presented By

Prof. Renato Lopes, Duke University Medical Center, USA

Trial

Coalition ACTION

Conference

ACC 2021

9 July, 2021 22:02

Atorvastatin does not reduce mortality in COVID-19

Presented By

Dr Behnood Bikdeli, Yale University School of Medicine, USA

Trial

INSPIRATION

Conference

ACC 2021

9 July, 2021 18:08

Valvular Heart Disease